Medical & Scientific Advisory Board

The Medical & Scientific Advisory Board (MSAB) provides strategic input, insight and expertise to Global Genes in the key areas of rare disease diagnostics, technology, drug development and potential partnerships related to rare disease science. The MSAB mission, goals and advisory role is strategically aligned with the Global Genes mission- To Eliminate the Challenges of Rare Disease.

This multidisciplinary board serves in an advisory capacity to the Global Genes executive leadership team and will convene quarterly to further specific initiatives as well as work together to broaden the impact of Global Genes by advancing innovation in technology, science, advocacy and research.

The MSAB consists of MDs, PhDs, MBAs, clinicians, geneticists, scientific researchers and professors.

View MSAB’s Statement of the Need for Undirected Research here.

 

2016 Medical & Scientific Advisory Board
Learn more about the MSAB by clicking their photos
beth-bordered hudson-freeze-border deb-g-border
Beth Ann Baber, PhD, MBA Hudson Freeze, MD, PhD Deb Geraghty, PhD, MBA
peter-goodhand-border steven-groft-border maureen-border
Peter Goodhand Steven Groft Maureen McArthur Hart, PhD
ayesha-border harry-leider-border c-jimmy-lin-border
Ayesha Khalid Harry Leider, MD, MBA, FACPE Jimmy Lin, MD, PhD, MHS
jeanette-mccarthy-border tim-miller-border sharon-moralem-border
Jeanette McCarthy, MPH, PhD Tim Miller, PhD Sharon Moalem, MD, PhD
ethan-perlstien-border anthony-p-border ian-phillips-border
Ethan Perlstein, PhD Anthony Philippakis, MD, PhD Ian Phillips, PhD, DSc
inderpal-border katherine-border christian-border
Inderpal Randhawa, MD Katherine Rauen, MD, MS, PhD Christian Rubio, MBA
alvin-shih-border ryan-taft-border keith-vaux-border
Alvin Shih, MD, MBA Ryan Taft, PhD Keith Vaux, MD, PhD